William Weldon is Chairman and Chief Executive Officer of Johnson & Johnson and is the sixth Chairman in Johnson & Johnson's over one-hundred year history.
Weldon joined J&J as a sales representative for the McNeil Pharameutical division in 1971 and eventually became the head of J&J's Ethicon Endo-Surgery business in 1992. He became the head of J&J's pharmaceutical operations in 1998 and then became J&J's CEO in 2002. As CEO, Weldon engineered some of the largest acquisitions in J&J's history including the purchase of ALZA and Pfizer's consumer-health product line.
William Weldon received a BA in Biology from Quinnipiac University.
Developing leadership and talent. It is the common trend, as I said, between all of these -- our Credo, our operating model and our priorities, and it will always be part of who we are, investing in the people. And we talked about managing for the long term, it's not just products and pipeline, it...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
